Abstract:Current tissue-regenerative biomaterials confront two critical issues: the uncontrollable delivery capacity of vascular endothelial growth factor (VEGF) for adequate vascularization and the poor mechanical properties of the system for tissue regeneration. To overcome these two issues, a self-assembling in situ gel based on lyotropic liquid crystals (LLC) was developed. VEGF-LLC was administrated as a precursor solution that would self-assemble into an in situ gel with well-defined internal inverse bicontinuous cubic phases when exposed to physiological fluid at a defect site. The inverse cubic phase with a 3D bicontinuous water channel enabled a 7-day sustained release of VEGF. The release profile of VEGF-LLC was controlled using octyl glucoside (OG) as a hydration-modulating agent, which could enlarge the water channel, yielding a 2-fold increase in water channel size and a 7-fold increase in VEGF release. For the mechanical properties, the elastic modulus was found to decrease from similar to 100 kPa to similar to 1.2 kPa, which might be more favorable for angiogenesis. Furthermore, the self-recovery ability of the VEGF-LLC gel was confirmed by quick recovery of the inner network in step-strain measurements. In vitro, VEGF-LLC considerably promoted the proliferation, migration, and tube formation of human umbilical vein endothelial cells (HUVECs) as compared to free VEGF (p < 0.05). Furthermore, angiogenesis was successfully induced in rats after subcutaneous injection of VEGF-LLC. The self-assembling LLC gel showed satisfactory degradability and mild inflammatory response with little impact on the surrounding tissue. The controllable release profile and unique mechanical properties of VEGF-LLC offer a new approach for tissue regeneration. Statement of Significance The potential clinical use of currently available biomaterials in tissue regeneration is limited by their uncontrollable drug delivery capacity and poor mechanical properties. Herein, a self-assembling in situ gel based on lyotropic liquid crystals (LLC) for induced angiogenesis was developed. The results showed that the addition of octyl glucoside (OG) could change the water channel size of LLC, which enabled the LLC system to release VEGF in a sustained manner and to possess a suitable modulus to favor angiogenesis simultaneously. Moreover, the self-recovery capability allowed the gel to match the deformation of surrounding tissues during body motion to maintain its properties and reduce discomfort. In vivo, angiogenesis was induced by VEGF-LLC 14 days after administering subcutaneous injection. These results highlight the potential of LLC as a promising sustained protein drug delivery system for vascular formation and tissue regeneration. (C) 2019 Published by Elsevier Ltd on behalf of Acta Materialia Inc.

Evolutionarily Conserved Sequence Motif Analysis Guides Development of Chemically Defined Hydrogels for Therapeutic Vascularization

Enzymatic Formation of an Injectable Hydrogel from a Glycopeptide As a Biomimetic Scaffold for Vascularization.

Injectable gelatin derivative hydrogels with sustained vascular endothelial growth factor release for induced angiogenesis

Anti-VEGF-R2 Aptamer and RGD Peptide Synergize in a Bifunctional Hydrogel for Enhanced Angiogenic Potential

Injectable and Tunable Gelatin Hydrogels Enhance Stem Cell Retention and Improve Cutaneous Wound Healing

Promotion of Microvasculature Formation in Alginate Composite Hydrogels by an Immobilized Peptide GYIGSRG

Interpenetrating Polymer Network HA/Alg-RGD Hydrogel: an Equilibrium of Macroscopic Stability and Microscopic Adaptability for 3D Cell Growth and Vascularization.

Hydrogels with Independently Controlled Adhesion Ligand Mobility and Viscoelasticity Increase Cell Adhesion and Spreading

Microfluidic Covalent Immobilization of Multi-gradient RGD Peptides on a Gelatin Surface for Studying Endothelial Cell Migration

Peptide Redv-Modified Polysaccharide Hydrogel with Endothelial Cell Selectivity for the Promotion of Angiogenesis

Dual-peptide-modified Alginate Hydrogels for the Promotion of Angiogenesis

Co-immobilization of adhesive peptides and VEGF within a dextran-based coating for vascular applications

Self-assembling in Situ Gel Based on Lyotropic Liquid Crystals Containing VEGF for Tissue Regeneration

Shear-thinning hydrogel for allograft cell transplantation and externally controlled transgene expression

Bioinspired Self-assembling Peptide Hydrogel with Proteoglycan-assisted Growth Factor Delivery for Therapeutic Angiogenesis

A Macrophage-Activating, Injectable Hydrogel to Sequester Endogenous Growth Factors for in Situ Angiogenesis.

In Vivo Studies on Angiogenic Activity of Two Designer Self-Assembling Peptide Scaffold Hydrogels in the Chicken Embryo Chorioallantoic Membrane

Tuneable Hybrid Hydrogels via Complementary Self-Assembly of a Bioactive Peptide with a Robust Polysaccharide

Biomimetic Hybrid Nanofiber Sheets Composed of RGD Peptide-Decorated PLGA as Cell-Adhesive Substrates

Pristine gelatin incorporation as a strategy to enhance the biofunctionality of poly(vinyl alcohol)-based hydrogels for tissue engineering applications

Designer Functionalized Self-Assembling Peptide Nanofiber Scaffolds for Growth, Migration, and Tubulogenesis of Human Umbilical Vein Endothelial Cells